TMPyP4 tosylate is a quadruplex-specific ligand that can inhibit the interaction between G-quadruplexes and Insulin-like growth factor type I (IGF-1)[1].
In vitro, TMPyP4 tosylate (50 or 100µM; 96h) significantly inhibited telomerase activity in telomerase positive HOS and Saos-2 cells, induced telomere shortening, and inhibited the cell growth in HOS and Saos-2 cells with over 17% apoptosis rates[2]. At a fixed irradiation fluence of 2.4J/cm², the photosensitization effect of TMPyP4 tosylate (10µM; 30min) resulted in more than three logs greater killing of C. albicans than methylene blue (MB) at the same incubation concentration[3].
In vivo, After applying an ethanol/glycerol/water formulation of TMPyP4 tosylate (0.3mg/mL; 30min) to the mouse ear, photodynamic therapy (PDT) was performed., the CFU count of Candida albicans in the infected ear was significantly reduced by approximately 50-fold compared to the untreated control group[3]. In the Lewis lung carcinoma model, mice treated with TMPyP4 tosylate (25µg/g/twice a week; 4 weeks; i.p.) exhibited significant inhibition of both primary tumor progression and lung metastasis development[4].
References:
[1] Chen H, Sun H, Chai Y, et al. Insulin-like growth factor type I selectively binds to G-quadruplex structures. Biochim Biophys Acta Gen Subj. 2019 Jan;1863(1):31-38.
[2] Fujimori J, Matsuo T, Shimose S, et al. Antitumor effects of telomerase inhibitor TMPyP4 in osteosarcoma cell lines. J Orthop Res. 2011 Nov;29(11):1707-11.
[3] Mitra S, Haidaris CG, Snell SB, et al. Effective photosensitization and selectivity in vivo of Candida Albicans by meso-tetra (N-methyl-4-pyridyl) porphine tetra tosylate. Lasers Surg Med. 2011 Apr;43(4):324-32.
[4] Aviezer D, Cotton S, David M, et al. Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis. Cancer Res. 2000 Jun 1;60(11):2973-80.
TMPyP4 tosylate是一种四链体特异性配体,可以抑制G-四链体与胰岛素样生长因子I(IGF-1)之间的相互作用[1]。
体外实验中,TMPyP4 tosylate(50或100µM; 96小时)显著抑制了端粒酶阳性HOS和Saos-2细胞中的端粒酶活性,诱导端粒缩短,并抑制了HOS和Saos-2细胞的生长,使细胞凋亡率超过17%[2]。在固定的光照射强度为2.4J/cm²的条件下,TMPyP4 tosylate(10µM; 30分钟)的光敏化效果对白色念珠菌的杀伤作用比相同浓度下亚甲蓝(MB)的效果高出三个数量级以上[3]。
体内实验中,使用乙醇/甘油/水配方的TMPyP4 tosylate(0.3mg/mL; 30分钟)涂抹在小鼠耳部进行光动力疗法(PDT)后,感染耳部的白色念珠菌的菌落形成单位(CFU)计数比未处理的对照组显著减少了约50倍[3]。在Lewis肺癌模型中,接受TMPyP4 tosylate(25µg/g/每周两次; 4周; 腹腔注射)治疗的小鼠表现出对原发肿瘤进展和肺转移发展的显著抑制作用[4]。
















